We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The clinical and biochemical hallmarks generally associated with GLUT1DS may be caused by defects in genes other than SLC2A1.
- Authors
Sánchez‐Lijarcio, Obdulia; Yubero, Delia; Leal, Fátima; Couce, María L.; González Gutiérrez‐Solana, Luis; López‐Laso, Eduardo; García‐Cazorla, Àngels; Pías‐Peleteiro, Leticia; de Azua Brea, Begoña; Ibáñez‐Micó, Salvador; Mateo‐Martínez, Gonzalo; Troncoso‐Schifferli, Monica; Witting‐Enriquez, Scarlet; Ugarte, Magdalena; Artuch, Rafael; Pérez, Belén
- Abstract
Glucose transporter 1 deficiency syndrome (GLUT1DS) is a neurometabolic disorder caused by haploinsufficiency of the GLUT1 glucose transporter (encoded by SLC2A1) leading to defective glucose transport across the blood–brain barrier. This work describes the genetic analysis of 56 patients with clinical or biochemical GLUT1DS hallmarks. 55.4% of these patients had a pathogenic variant of SLC2A1, and 23.2% had a variant in one of 13 different genes. No pathogenic variant was identified for the remaining patients. Expression analysis of SLC2A1 indicated a reduction in SLC2A1 mRNA in patients with pathogenic variants of this gene, as well as in one patient with a pathogenic variant in SLC9A6, and in three for whom no candidate variant was identified. Thus, the clinical and biochemical hallmarks generally associated with GLUT1DS may be caused by defects in genes other than SLC2A1.
- Publication
Clinical Genetics, 2022, Vol 102, Issue 1, p40
- ISSN
0009-9163
- Publication type
Article
- DOI
10.1111/cge.14138